Depot formulations to sustain periocular drug delivery to the posterior eye segment

被引:38
作者
Agban, Yosra [1 ]
Thakur, Sachin S. [1 ]
Mugisho, Odunayo O. [1 ]
Rupenthal, Ilva D. [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, New Zealand Natl Eye Ctr, Dept Ophthalmol,Buchanan Ocular Therapeut Unit, Private Bag 92019, Auckland 1142, New Zealand
关键词
BIODEGRADABLE INTRASCLERAL IMPLANT; INTRAVITREAL CONTROLLED-RELEASE; RETINAL-PIGMENT EPITHELIUM; TRANSSCLERAL DELIVERY; TRIAMCINOLONE ACETONIDE; HUMAN SCLERA; SUBCONJUNCTIVAL INJECTION; ANECORTAVE ACETATE; POLYMERIC DEVICE; NANO-PARTICLES;
D O I
10.1016/j.drudis.2019.03.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The periocular space is a promising alternative route for the delivery of drugs to the posterior eye segment, especially when treating conditions in the outer ocular layers. In this review, we discuss the different periocular routes as well as the physiological barriers and elimination mechanisms limiting drug bioavailability at the back of the eye. We then highlight various types of depot formulations, including particulate delivery systems, semisolid formulations, and implants, used to increase the contact time with the ocular tissues. With the additional advantage of sustaining drug release, such depot formulations could enhance periocular drug delivery to the posterior eye segment.
引用
收藏
页码:1458 / 1469
页数:12
相关论文
共 111 条
[1]   Injectable implants for the sustained release of protein and peptide drugs [J].
Agarwal, Priyanka ;
Rupenthal, Ilva D. .
DRUG DISCOVERY TODAY, 2013, 18 (7-8) :337-349
[2]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
[3]  
Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
[4]   P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[5]   Colloidal drug delivery system: amplify the ocular delivery [J].
Ameeduzzafar ;
Ali, Javed ;
Fazil, Mohd ;
Qumbar, Mohd ;
Khan, Nazia ;
Ali, Asgar .
DRUG DELIVERY, 2016, 23 (03) :710-726
[6]   Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration [J].
Amrite, AC ;
Kompella, UB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (12) :1555-1563
[7]   Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology [J].
Andres-Guerrero, Vanessa ;
Zong, Mengmeng ;
Ramsay, Eva ;
Rojas, Blanca ;
Sarkhel, Sanjay ;
Gallego, Beatriz ;
de Hoz, Rosa ;
Ramirez, Ana I. ;
Salazar, Juan Jose ;
Trivino, Alberto ;
Ramirez, Jose M. ;
del Amo, Eva M. ;
Camerong, Neil ;
de-las-Heras, Beatriz ;
Urtti, Arto ;
Mihov, George ;
Dias, Aylvin ;
Herrero-Vanrell, Rocio .
JOURNAL OF CONTROLLED RELEASE, 2015, 211 :105-117
[8]  
Attar Mayssa, 2005, Expert Opin Drug Deliv, V2, P891, DOI 10.1517/17425247.2.5.891
[9]   Anecortave acetate in the treatment of age-related macular degeneration [J].
Augustin, Albert .
CLINICAL INTERVENTIONS IN AGING, 2006, 1 (03) :237-246
[10]   Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model [J].
Ayalasomayajula, SP ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 511 (2-3) :191-198